BLENREP Re-launch
CAMPAIGN LAUNCH: BLENREP is a GSK launched prescription medicine used to treat some adults with multiple myeloma. It was pulled from the U.S. market in November 2022 and re-launched in 2025. For this new launch created all-new branding, a reimagined logo, brand identity, and fresh campaign materials such as brochures, journal ads, banner ads, and their website on the DTC side.
Produced by Area 23
Campaign Imagery
Iconography
Print and Digital Pieces
